Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Corporativo FraguaB de CVMEX:FRAGUAB +3.44%84 ROE % is 20.43% as of Dec. 2024, which is 53% above its 10-year median of 13.31. GuruFocus rates MEX:FRAGUAB with a GF Score™ of 84/100 and a GF Value™ of MXN697.68 (Significantly Undervalued). Among 621 Healthcare Providers & Services companies, Corporativo FraguaB de CV ranks better than 85.19% on this metric.
The historical rank and industry rank for Corporativo FraguaB de CV's ROE % or its related term are showing as below:
MEX:FRAGUAB'
s ROE % Range Over the Past 10 Years
Min: 11.46 Med: 13.31 Max: 21.59
Current: 20.43
During the past 13 years, Corporativo FraguaB de CV's highest ROE % was 21.59%. The lowest was 11.46%. And the median was 13.31%.
MEX:FRAGUAB's ROE % is ranked better than 85.19% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 5.88
vs MEX:FRAGUAB: 20.43
Corporativo FraguaB de CV (MEX:FRAGUAB) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is one times the annual (Dec. 2024) net income data. The Revenue data used here is one times the annual (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Corporativo FraguaB de CV ROE % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Corporativo FraguaB de CV's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Corporativo FraguaB de CV ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Corporativo FraguaB de CV's ROE % distribution charts can be found below:
* The bar in red indicates where Corporativo FraguaB de CV's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Dec. 2024) net income data.
ROE % is displayed in the 30-year financial page.
Corporativo FraguaB de CV (MEX:FRAGUAB) has a ROE % of 20.43% as of Dec. 2024. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Corporativo FraguaB de CV and its competitors. This is 53% above median its historical median of 13.31. Over the past decade, Corporativo FraguaB de CV's ROE % has ranged from 11.46 to 21.59. According to the industry distribution chart, Corporativo FraguaB de CV ranks #92 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 14.8%.
Is Corporativo FraguaB de CV's ROE % too high?
Corporativo FraguaB de CV's current ROE % of 20.43% is 53% above median its 10-year median of 13.31. Over the past 10 years, this metric has ranged from a low of 11.46 to a high of 21.59. The Healthcare Providers & Services industry median ROE % is 5.88. Corporativo FraguaB de CV's value of 20.43% is 247.4% above this industry median. Based on the distribution chart, Corporativo FraguaB de CV ranks #92 out of 621 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Corporativo FraguaB de CV has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Corporativo FraguaB de CV's ROE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Corporativo FraguaB de CV ranks #92 out of 621 companies for ROE %. This places Corporativo FraguaB de CV in the top 15% of its industry — outperforming the majority of peers. The industry median ROE % is 5.88. Corporativo FraguaB de CV's value of 20.43% is 247.4% above this benchmark. Historically, Corporativo FraguaB de CV's own ROE % has ranged from 11.46 to 21.59 over the past decade. While the company's 10-year median is 13.31 vs. the industry median of 5.88, Corporativo FraguaB de CV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Corporativo FraguaB de CV's current ROE % of 20.43% is 247.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Corporativo FraguaB de CV and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corporativo FraguaB de CV's current ROE % is 20.43%, which is 53% above median its own 10-year median of 13.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corporativo FraguaB de CV stock overvalued right now?
Based on GuruFocus' analysis, Corporativo FraguaB de CV (MEX:FRAGUAB) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN697.68, compared to a current price of MXN479.99 — trading 31.2% below its estimated fair value. The current ROE % is 20.43%, which is 53% above median its 10-year median of 13.31 and 247.4% above the Healthcare Providers & Services industry median of 5.88. Corporativo FraguaB de CV's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Corporativo FraguaB de CV (MEX:FRAGUAB), the current ROE % is 20.43% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Corporativo FraguaB de CV (MEX:FRAGUAB) Overvalued in 2026?
Based on GuruFocus' analysis, Corporativo FraguaB de CV stock appears to be undervalued.
The current stock price of MXN479.99 is trading 31.2% below its estimated GF Value™ of MXN697.68.
GuruFocus considers Corporativo FraguaB de CV to be Significantly Undervalued.
Key valuation signals for MEX:FRAGUAB:
ROE %: 20.43% (53% above median its 10-year median of 13.31)
GF Value™: MXN697.68 vs. price of MXN479.99 (31.2% below fair value)
Industry Position: 247.4% above the Healthcare Providers & Services median (#92 of 621)
No single metric tells the full story. See the MEX:FRAGUAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
84GF Score
Get the complete analysis for MEX:FRAGUAB
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:FRAGUAB has been successfully added to your 
